Household factors and the risk of severe COVID-like illness early in the U.S. pandemic.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 11 01 2021
accepted: 07 07 2022
entrez: 21 7 2022
pubmed: 22 7 2022
medline: 26 7 2022
Statut: epublish

Résumé

To investigate the role of children in the home and household crowding as risk factors for severe COVID-19 disease. We used interview data from 6,831 U.S. adults screened for the Communities, Households and SARS/CoV-2 Epidemiology (CHASING) COVID Cohort Study in April 2020. In logistic regression models, the adjusted odds ratio [aOR] of hospitalization due to COVID-19 for having (versus not having) children in the home was 10.5 (95% CI:5.7-19.1) among study participants living in multi-unit dwellings and 2.2 (95% CI:1.2-6.5) among those living in single unit dwellings. Among participants living in multi-unit dwellings, the aOR for COVID-19 hospitalization among participants with more than 4 persons in their household (versus 1 person) was 2.5 (95% CI:1.0-6.1), and 0.8 (95% CI:0.15-4.1) among those living in single unit dwellings. Early in the US SARS-CoV-2 pandemic, certain household exposures likely increased the risk of both SARS-CoV-2 acquisition and the risk of severe COVID-19 disease.

Identifiants

pubmed: 35862418
doi: 10.1371/journal.pone.0271786
pii: PONE-D-21-00955
pmc: PMC9302833
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0271786

Subventions

Organisme : NICHD NIH HHS
ID : P2C HD050924
Pays : United States

Commentaires et corrections

Type : UpdateOf

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
MMWR Morb Mortal Wkly Rep. 2020 Nov 06;69(44):1631-1634
pubmed: 33151916
J Pediatric Infect Dis Soc. 2020 Nov 10;9(5):613-616
pubmed: 32780809
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
N Engl J Med. 2020 Apr 23;382(17):1663-1665
pubmed: 32187458
Commun Med (Lond). 2023 Jun 30;3(1):92
pubmed: 37391483
JAMA Netw Open. 2020 May 1;3(5):e2010182
pubmed: 32459353
Clin Infect Dis. 2020 Nov 5;71(8):1953-1959
pubmed: 32382743
MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):377-381
pubmed: 32240128
medRxiv. 2020 Sep 30;:
pubmed: 33024982
Ann Intern Med. 2020 May 05;172(9):577-582
pubmed: 32150748
J Infect. 2021 Oct;83(4):483-489
pubmed: 34348116
Int J Infect Dis. 2020 Aug;97:290-292
pubmed: 32553720
Emerg Infect Dis. 2020 Jun;26(6):1339-1441
pubmed: 32168463
N Engl J Med. 2020 Jun 11;382(24):2302-2315
pubmed: 32289214
Clin Infect Dis. 2022 Jan 7;74(1):52-58
pubmed: 33822007
Science. 2020 Nov 6;370(6517):691-697
pubmed: 33154136
Front Pediatr. 2022 Jan 05;9:752993
pubmed: 35071125
Int J Environ Res Public Health. 2020 Aug 21;17(17):
pubmed: 32825563
JAMA Pediatr. 2020 Sep 1;174(9):902-903
pubmed: 32745201
Clin Infect Dis. 2020 Nov 5;71(8):1960-1961
pubmed: 32526016
Biosci Trends. 2020 Jul 17;14(3):206-208
pubmed: 32321904
J Med Virol. 2021 Mar;93(3):1414-1420
pubmed: 32767703
N Engl J Med. 2020 Oct 29;383(18):e101
pubmed: 32897661
Clin Infect Dis. 2021 Oct 5;73(7):e1841-e1849
pubmed: 32719874
Science. 2021 Jan 15;371(6526):
pubmed: 33234698
MMWR Morb Mortal Wkly Rep. 2020 Sep 11;69(36):1250-1257
pubmed: 32915166
J Gen Intern Med. 2020 Oct;35(10):3063-3066
pubmed: 32737790
JAMA Netw Open. 2020 Dec 1;3(12):e2031756
pubmed: 33315116
Explor Res Hypothesis Med. 2020 Jul 08;:1-10
pubmed: 32734759
Arch Dis Child. 2021 Dec;106(12):1212-1217
pubmed: 33737319
J Urban Health. 2020 Aug;97(4):461-470
pubmed: 32691212
Clin Infect Dis. 2023 Feb 8;76(3):e375-e384
pubmed: 35639911
BMJ Open. 2021 Sep 21;11(9):e048778
pubmed: 34548354

Auteurs

Denis Nash (D)

Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York City, New York, United States of America.
Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York City, New York, United States of America.

Saba Qasmieh (S)

Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York City, New York, United States of America.
Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York City, New York, United States of America.

McKaylee Robertson (M)

Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York City, New York, United States of America.
Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York City, New York, United States of America.

Madhura Rane (M)

Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York City, New York, United States of America.

Rebecca Zimba (R)

Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York City, New York, United States of America.
Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York City, New York, United States of America.

Sarah G Kulkarni (SG)

Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York City, New York, United States of America.

Amanda Berry (A)

Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York City, New York, United States of America.

William You (W)

Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York City, New York, United States of America.

Chloe Mirzayi (C)

Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York City, New York, United States of America.
Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York City, New York, United States of America.

Drew Westmoreland (D)

Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York City, New York, United States of America.

Angela Parcesepe (A)

Department of Maternal and Child Health, Gillings School of Public Health, University of North Carolina, Chapel Hill, North Carolina, United States of America.
Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

Levi Waldron (L)

Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York City, New York, United States of America.
Department of Environmental, Occupational, and Geospatial Health Sciences, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York City, New York, United States of America.

Shivani Kochhar (S)

Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York City, New York, United States of America.

Andrew R Maroko (AR)

Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York City, New York, United States of America.
Department of Environmental, Occupational, and Geospatial Health Sciences, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York City, New York, United States of America.

Christian Grov (C)

Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York City, New York, United States of America.
Department of Community Health and Social Sciences, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York City, New York, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH